12 companies

Rubicon Research

Market Cap: ₹282.9b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

RUBICON

₹1,708.80

7D

-5.3%

1Y

n/a

Acutaas Chemicals

Market Cap: ₹271.3b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹3,313.40

7D

-2.3%

1Y

134.4%

Sakar Healthcare

Market Cap: ₹19.7b

Research, develops, manufactures, and sells pharmaceutical products in India.

SAKAR

₹884.85

7D

-1.0%

1Y

166.6%

Aether Industries

Market Cap: ₹216.8b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹1,633.90

7D

0.02%

1Y

122.0%

CORONA Remedies

Market Cap: ₹128.3b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,097.30

7D

-1.0%

1Y

n/a

Anthem Biosciences

Market Cap: ₹492.6b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

ANTHEM

₹874.70

7D

-1.8%

1Y

4.6%

Emcure Pharmaceuticals

Market Cap: ₹350.3b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹1,846.90

7D

-1.5%

1Y

25.8%

Senores Pharmaceuticals

Market Cap: ₹68.2b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

SENORES

₹1,480.40

7D

-3.7%

1Y

109.3%

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹387.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

506943

₹2,412.25

7D

0%

1Y

40.5%

Laurus Labs

Market Cap: ₹1.0t

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,866.20

7D

2.9%

1Y

114.8%

Shilpa Medicare

Market Cap: ₹168.6b

Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.

530549

₹862.15

7D

6.4%

1Y

109.4%

Supriya Lifescience

Market Cap: ₹63.7b

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

SUPRIYA

₹791.65

7D

-1.2%

1Y

20.3%